Janet Huffman - Sep 19, 2024 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Chief Financial Officer
Signature
/s/ Julio C. Esquivel, as Attorney-in-Fact for Janet Huffman
Stock symbol
OGEN
Transactions as of
Sep 19, 2024
Transactions value $
$0
Form type
4
Date filed
9/20/2024, 09:15 PM
Previous filing
Aug 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Employee Option (Right to Buy) Award $0 +80K $0.00 80K Sep 19, 2024 Common Stock 80K $0.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.